Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Part of paid clinical trials in Durham, North Carolina.
- Sponsor
- Bastiaan Driehuys
- Study ID
- NCT01280994
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Interstitial Lung Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Hyperpolarized 129Xenon Gas — DRUGHyperpolarized 129Xenon Gas will be administered in multiple doses in volumes that are tailored to the subject's total lung capacity (TLC) followed by a breath hold of up to 15 seconds. Subsequent 129Xe doses will only be administered once the subject is ready to proceed.
Study Details
The purpose of this study is to develop and evaluate the usefulness of MRI using 129Xe gas for regional assessment of pulmonary function. Specifically, three forms of 129Xe MRI contrast will be the investigators focus - 1) imaging of the 129Xe ventilation distribution, 2) imaging the alveolar microstructure via the 129Xe apparent diffusion coefficient (ADC), and 3) imaging 129Xe that dissolves in the pulmonary blood and tissues upon inhalation. Such imaging of 129Xe gas transfer is expected to be uniquely sensitive to pathologies affecting gas exchange (fibrosis, emphysema, pulmonary hypertension) and provide new insights regarding the normal resting heterogeneity of pulmonary gas exchange.
Key Dates
- Start date
- Jan 31, 2011
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 445 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Primary Outcome Measure
Number of Participants with Adverse Events as a Measure of Safety and Tolerability [ Time Frame: Day 2 ]
Central Contacts
- Jennifer Korzekwinski919-681-7362
- Cody Blanton919-668-7575
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Duke University Medical Center | Durham | North Carolina | 27710 | Bastiaan Driehuys, Ph.D (PRINCIPAL_INVESTIGATOR) Joseph Mammarappallil, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Durham, NC
Related Studies
- Pulmonary Hypertension SOLARPHASE2 · Recruiting · Bastiaan Driehuys · Durham, North Carolina
- Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung DiseasePHASE3 · Enrolling By Invitation · United Therapeutics · Birmingham, Alabama
- Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung DiseasePHASE2 · Recruiting · Children's Hospital Medical Center, Cincinnati · San Francisco, California
- Global Utilization And Registry Database for Improved preservAtion of doNor LUNGsEnrolling By Invitation · Paragonix Technologies · Phoenix, Arizona